Sapropterin in the Treatment of Phenylketonuria

Clinical Medicine Insights: Therapeutics- New Zealand

doi 10.4137/cmt.s2721

Full Text

Abstract

Available in

Date

Authors

Publisher

SAGE Publications

Related search

A Systematic Review of BH4 (Sapropterin) for the Adjuvant Treatment of Phenylketonuria

JIMD Reports
Internal MedicineGeneticsMolecular BiologyBiochemistryEndocrinologyMetabolismDiabetes
2012English

Longitudinal Quality of Life Analysis in a Phenylketonuria Cohort Provided Sapropterin Dihydrochloride

Health and Quality of Life Outcomes
MedicineEnvironmentalPublic HealthOccupational Health
2013English

Sapropterin Dihydrochloride (6r-Bh4) and Maternal Phenylketonuria Two Case Studies

ICAN: Infant, Child, & Adolescent Nutrition
2009German

Treatment of Phenylketonuria

Journal of Pediatrics
Child HealthPediatricsPerinatology
1967English

The Dietary Treatment of Phenylketonuria

International Journal of Food Sciences and Nutrition
Food Science
1959English

Conventional Phenylketonuria Treatment

Journal of Inborn Errors of Metabolism and Screening
Child HealthGeneticsEndocrinologyPerinatologyPediatricsMetabolismDiabetes
2016English

Termination of Dietary Treatment for Phenylketonuria

JAMA - Journal of the American Medical Association
Medicine
1963English

681. rDNA-AAV Vectors for the Treatment of Phenylketonuria

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2010English

Phenylketonuria in Children: Modern Aspects of Pathogenesis, Clinic, Treatment

Rossiyskiy Vestnik Perinatologii i Pediatrii
Child HealthPediatricsPerinatology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy